Rovia Clinical Research
Rovia Clinical Research is a US-based multi-specialty clinical research site network operating 17 wholly owned sites that partner with community physicians to execute clinical trials for global pharmaceutical sponsors, biotechs, and CROs, generating revenue through per-study and milestone-based contracts.
- Company typePrivate
- Founded2007
- HeadquartersJacksonville, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Rovia Clinical Research does
Rovia Clinical Research is a U.S.-based multi-specialty clinical research site network founded in 2007 and headquartered in Jacksonville, Florida. The company operates 17 wholly owned research sites across Florida, Mississippi, Georgia, Louisiana, Tennessee, Missouri, and North Carolina, combining free-standing research sites with sites embedded in community physician offices. Through these community physician partnerships, Rovia maintains direct electronic medical record (EMR) access for patient identification and recruitment, which is the core technological enabler of its operating model. The company delivers rapid study start-up, patient enrollment, and high-quality data to enterprise customers including major global pharmaceutical companies, biotechnology companies, and contract research organizations (CROs).
Rovia's service offering is fundamentally a professional services / site-management model rather than a software product. Revenue is generated through contract fees for executing clinical trials on behalf of sponsors, typically structured as per-study or milestone-based arrangements. Centralized teams handle activation, patient recruitment, and oversight, while site-level staff execute protocols and manage participants. The company cites 18+ years of operational experience, 100% reported patient satisfaction, and embedded community physician relationships as its primary competitive differentiators. Recent operating activity in 2025 includes the acquisition of Studymetrix Research and Coastal Research Institute, a new site partnership with Hattiesburg Clinic, and a senior loan from Marathon Asset Management to fund continued expansion.
Go-to-market is enterprise field sales—Rovia contracts directly with global pharma sponsors, biotechs, and CROs seeking fast study activation, enrollment performance, and access to diverse patient populations across multiple therapeutic areas. The customer base is segmented into pharmaceutical sponsors, biotech companies, CROs, and patients (the latter accessed via community physician referrals and a Refer-a-Friend program offering up to $100 gift cards). The company reports HIPAA compliance and applies state-level data protection protocols in its Florida, Tennessee, and Louisiana operations. Pricing is not publicly disclosed, consistent with its B2B contract-services model.
Rovia Clinical Research firmographics
Firmographics- Name
- Rovia Clinical Research
- Legal name
- Rovia Clinical Research LLC
- Website
- https://roviaclinical.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Rovia Clinical Research is a US-based multi-specialty clinical research site network operating 17 wholly owned sites that partner with community physicians to execute clinical trials for global pharmaceutical sponsors, biotechs, and CROs, generating revenue through per-study and milestone-based contracts.
- Ownership category
- akta.pro rank
Rovia Clinical Research industry classification
Industry- Product category
- Clinical Research Site Network Services
- NAICS
- Professional, Scientific, and Technical Services (54), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Site Network Operators & SMOs (HLAGACAA)
- akta.pro secondary industries
- Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Site Identification & Feasibility (HLAGACAB)
Keywords
Where Rovia Clinical Research is headquartered
LocationHeadquarters
- HQ city
- Jacksonville
- HQ country
- United States
- HQ region
- North America
Offices14 records
Markets served
Rovia Clinical Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Clinical Trial Services: Rovia generates revenue by executing clinical trials on behalf of pharmaceutical sponsors, biotech companies, and CROs. The company provides site-based clinical research services including patient enrollment, study execution, and data delivery. Revenue is earned through contract fees for study execution, typically structured as per-study or milestone-based arrangements.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Rovia Clinical Research product offering
Product offeringCore offering
Rovia Clinical Research operates a U.S.-based network of 17 wholly owned multi-specialty clinical research sites that contract directly with pharmaceutical sponsors, biotech companies, and CROs to execute clinical trials. Services include rapid study start-up, centralized patient recruitment, enrollment and retention across diverse patient populations, and standardized study execution with centralized oversight and SOPs. The company combines free-standing sites with sites embedded in community physician offices to enable direct EMR access and efficient patient identification.
Product overview
Rovia Clinical Research operates as a clinical trial management service provider with a network of 17 wholly owned research sites across the United States. The company offers centralized patient recruitment, rapid study activation, enrollment target achievement, and consistent high-quality study execution. Services include rapid study start-up through dedicated centralized teams, compassionate patient care with flexible scheduling, and centralized oversight with reliable SOPs. The company partners with major global pharmas, biotechs, and CROs to deliver fast study start-up, patient enrollment, and high-quality data delivery with access to diverse patient populations. No discrete named software products or modules are identified—the offering is fundamentally a service-based model centered on the physical site network and operational expertise.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Research Site Network Services U.S.-based multi-specialty clinical research site network of 17 wholly owned sites providing rapid study start-up, centralized patient recruitment, enrollment, retention, and high-quality data delivery to pharmaceutical sponsors, biotech companies, and CROs. Services are delivered through a mix of free-standing sites and physician-office-embedded sites with direct EMR access.
- Rapid Study Start-Up Services Dedicated centralized teams that streamline activation and prioritize rapid first patient enrollment across the site network for sponsor trials.
- Enrollment, Retention & Diversity Services Patient enrollment, retention, and diversity services delivered through 17 sites, patient-centered physicians, and flexible scheduling with reported 100% patient satisfaction.
- Quality & Compliance Study Execution Services Centralized oversight, reliable SOPs, and timely data practices ensuring consistent, compliant, and high-quality study execution across every site, with patient safety as the top priority.
Quantifiable outcome
- 17 sites across multiple U.S. states providing broad geographic reach and patient access
- +2 more outcomes
Companies that use Rovia Clinical Research
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
Rovia Clinical Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Rovia Clinical Research partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Hattiesburg CliniccoreRovia Clinical Research announced a partnership with Hattiesburg Clinic to launch a new clinical research site at Hattiesburg, Mississippi, in partnership with Dr. Rambod Rouhbakhsh. This expansion strengthens Rovia's presence in Mississippi and enhances capabilities in strategic therapeutic areas.
- Dr. Rambod RouhbakhshcoreDr. Rambod Rouhbakhsh serves as the physician partner for the new Hattiesburg Clinic research site, bringing expertise to strengthen Rovia's research capabilities in Mississippi.
Scale indicators3 records
Recent moves7 records
Expansion highlights5 records
Rovia Clinical Research competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Rovia Clinical Research social profiles
Digital presenceRovia Clinical Research compliance and trust
Trust signalCompliance5 records
Rovia Clinical Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Rovia Clinical Research leadership team
Management profileNumber of profiles
Profiles6 records
Rovia Clinical Research funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Rovia Clinical Research M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Rovia Clinical Research
What does Rovia Clinical Research do?
Rovia Clinical Research operates a U.S.-based network of 17 wholly owned multi-specialty clinical research sites that contract directly with pharmaceutical sponsors, biotech companies, and CROs to execute clinical trials. Services include rapid study start-up, centralized patient recruitment, enrollment and retention across diverse patient populations, and standardized study execution with centralized oversight and SOPs. The company combines free-standing sites with sites embedded in community physician offices to enable direct EMR access and efficient patient identification.
Is Rovia Clinical Research a public or private company?
Rovia Clinical Research is a private company. It is classified as unknown and is currently operating.
When was Rovia Clinical Research founded?
Rovia Clinical Research was founded in 2007. It employs 51 to 100 people.
Where is Rovia Clinical Research based?
Rovia Clinical Research is headquartered in Jacksonville, United States, in the North America region.
How does Rovia Clinical Research make money?
One revenue line is on record: clinical Trial Services.
Does Rovia Clinical Research have an API?
No public API is recorded for Rovia Clinical Research.
What industry is Rovia Clinical Research in?
Rovia Clinical Research's product category is Clinical Research Site Network Services. Its primary akta.pro industry code is HLAGACAA, Site Network Operators & SMOs, with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 54 and its SIC code is 8000.